Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid regimens to reduce blood loss in sarcoma surgery
2016-003214-27Phase 3Active
- Sponsor
- Irene Barrientos Ruiz
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in bone cancer and soft tissue sarcoma (STS) (3 arms), sponsored by Irene Barrientos Ruiz. Primary endpoint: Blood loss via surgical drainage. Started Dec 2016; status: active.
02
Drugs
tranexamic acid
03
Conditions
bone cancersoft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2016-003214-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003214-27.